Literature DB >> 17119888

[Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation].

T Wobrock1, D Kadovic, P Falkai.   

Abstract

Abnormalities in brain plasticity, including abnormal information processing by disturbed cortical inhibition and facilitation in schizophrenia, have been described several times in the past. Transcranial magnetic stimulation (TMS) provides a neurophysiological technique for the measurement of cortical excitability, especially of the motoneural system. With TMS it is possible to explore important aspects of the pathophysiological mechanisms underlying schizophrenia using recently developed paradigms (paired pulse method, cortical silent period). This review summarizes the results of available diagnostic TMS studies in schizophrenia. Studies investigating the efficacy of therapeutic repetitive magnetic stimulation in patients with treatment resistant hallucinations or predominantly negative symptoms were not considered. The reviewed studies support the assumption of reduced cortical inhibition, probably caused by GABAergic deficit, in schizophrenia. Factors influencing the study results, the limitations of this promising technique in schizophrenia, and further research options are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17119888     DOI: 10.1007/s00115-006-2207-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  41 in total

1.  Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation.

Authors:  Zafiris J Daskalakis; Bruce K Christensen; Robert Chen; Paul B Fitzgerald; Robert B Zipursky; Shitij Kapur
Journal:  Psychopharmacology (Berl)       Date:  2003-08-07       Impact factor: 4.530

2.  Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia.

Authors:  N J Davey; B K Puri; H S Lewis; S W Lewis; P H Ellaway
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

3.  Variability of motor potentials evoked by transcranial magnetic stimulation.

Authors:  L Kiers; D Cros; K H Chiappa; J Fang
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1993-12

Review 4.  [Repetitive transcranial magnetic stimulation. Possibilities, limits and safety aspects].

Authors:  S A Brandt; C J Ploner; B U Meyer
Journal:  Nervenarzt       Date:  1997-10       Impact factor: 1.214

5.  An investigation of motor function in schizophrenia using transcranial magnetic stimulation of the motor cortex.

Authors:  B K Puri; N J Davey; P H Ellaway; S W Lewis
Journal:  Br J Psychiatry       Date:  1996-12       Impact factor: 9.319

6.  A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation.

Authors:  P B Fitzgerald; T L Brown; Z J Daskalakis; A deCastella; J Kulkarni
Journal:  Schizophr Res       Date:  2002-08-01       Impact factor: 4.939

Review 7.  Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain.

Authors:  F M Benes
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

8.  Ketamine increases human motor cortex excitability to transcranial magnetic stimulation.

Authors:  V Di Lazzaro; A Oliviero; P Profice; M A Pennisi; F Pilato; G Zito; M Dileone; R Nicoletti; P Pasqualetti; P A Tonali
Journal:  J Physiol       Date:  2003-01-17       Impact factor: 5.182

9.  Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.

Authors:  U Ziemann; S Lönnecker; B J Steinhoff; W Paulus
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

10.  Central fatigue as revealed by postexercise decrement of motor evoked potentials.

Authors:  J P Brasil-Neto; L G Cohen; M Hallett
Journal:  Muscle Nerve       Date:  1994-07       Impact factor: 3.217

View more
  1 in total

Review 1.  The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia.

Authors:  Samuel M Cohen; Richard W Tsien; Donald C Goff; Michael M Halassa
Journal:  Schizophr Res       Date:  2015-01-09       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.